DAIVOREM PLUS
BIOREM
Identification
- Active ingredient (INN)
- CALCIPOTRIOL SOUS FORME DE CALCIPOTRIOL HYDRATE/BETAMETHASONE SOUS FORME DE DIPROOIONATE DE BETAMETHASONE
- Internal code
- 07 S 152
- Country of Origin
- Algeria
- Pharmaceutical form
- Ointment
- Prescription List
- Highly Regulated (List I)
- Packaging
- t/60g
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Indications
Used on skin to treat coronary in adults.
Associated Conditions
Medically supervised and carefully used during pregnancy and breastfeeding; severe cases of liver or kidney disease; diabetes patients; viral, innate or bacterial infection; and the existence of youth love.
Mechanism of Action
A distinctive combination of shell therapy and reduction of associated infections contains the following active substances: cybutryol: recovering the rate of growth of skin cells to normal, thus helping to treat light to medium-sized cases of shell.
Cassibutriol is a vitamin D
Betamethazone derivative: strong corticosteroid, reducing swelling, redness, and itchy associated with skin infection, by discouraging immune response and reducing the vascular permeability of hairs, helping to resist pain and infection.